In an unexpected turn of events, Telesis Bio, Inc. (NASDAQ: TBIO) witnessed an extraordinary surge in its stock price, sending shockwaves through the market. The
The Translate Bio Inc. (TBIO) stock lost 22.10% in the pre-market trading on Thursday, March 18 2021 after TBIO announced the clinical trial results of
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.